Advanced Patent Workshop "Master Class" for Pharmaceutical R&D Professionals  | KN 3201

How to effectively manage the IP interface 04.04. - 05.04.2019 | Berlin, Germany


Victor's Residenz-Hotel Berlin
Am Friedrichshain 17
10407 Berlin
Tel.:+49 (0) 30 21914-0
Fax:+49 (0) 30 21914-199

Kursprogramm zum Download


This hands-on training course targets pharmaceutical professionals and managers who have a good working knowledge of pharmaceutical patents and who have already gained significant experience at the interface of R&D and IP.
Typical roles of participants include:

  • R&D managers with IP responsibilities
  • IP champions and IP liaison managers within R&D organisations
  • Experts in licensing & due diligence teams
  • Technology analysts


The main objective is to enable the participants to further advance their cross-functional capabilities and be prepared for assuming roles within R&D which include substantial responsibilities at the IP interface.
In particular, the successful participant will be able to
(1) Raise the awareness of IP issues within R&D organisations and translate them into language that is understood by R&D experts
(2) Collaborate effectively with R&D and IP experts and facilitate high-quality assessments of potential inventions with respect to their patentability
(3) Collaborate effectively with R&D and IP experts and facilitate high-quality assessments of third party patents and their potential impact
(4) Take or contribute to key decisions requiring a thorough understanding of R&D- and IP-related risks


Pharma Patents International AG


Karsten Cremer, PhD

Karsten Cremer, PhD, brings in the ideal expertise for leading this patent course. He is a European patent attorney and a pharmaceutical scientist with many years of professional experience in IP, but also in drug delivery and drug product development. Through his intimate knowledge from both sides of the fence, he has become a successful trainer for pharmaceutical professionals who tackle patent challenges relating to drug products, dosage form designs, formulations, kits and manufacturing methods.
Karsten is founder and managing partner of Pharma Concepts GmbH, a pharmaceutical IP company based in Basel and Berlin. In previous appointments, he was CEO of Capsulution NanoScience AG, Director of Oral Drug Delivery at LTS Lohmann Therapy Systems, and lecturer of Pharmaceutics at the University of Marburg. As a pharmaceutical IP expert, Karsten works with large pharmaceutical companies as well as small and medium-size drug delivery companies. His specialties include IP issues relating to pharmaceutical formulations and drug delivery technologies. In addition to drafting, filing and prosecuting patent applications, he is experienced in opposing and defending patents, developing and implementing tailor-made patent strategies, managing patent portfolios, establishing patent landscapes, performing freedom-to-operate analyses, and conducting technical and IP due diligences.
Karsten is an experienced speaker and tutor with a proven track record of success within the APV and other professional organisations. He is also the founder and former chairman of the APV Drug Delivery Focus Group.

Kurt Schellhaas, PhD

Kurt Schellhaas, PhD, joined Pharma Concepts in 2016 as a Senior Associate on the basis of more than 15 years of professional experience in academia and industry. He completed his studies in Chemistry at J. W. Goethe University, Frankfurt and holds a Ph.D. in Organic Chemistry from Technical University Berlin. After his postdoctoral studies at the Scripps Institution of Oceanography at the University of California, La Jolla he joined BASF SE as a medicinal chemist. In 2002, Kurt decided to focus his professional career on the field of Intellectual Property and joined the BASF
Global IP department where he worked as a European Patent Attorney and Senior Patent Counsel in the field of vitamins and precursors thereof, APIs and pharmaceutical intermediates as well as aroma chemicals covering a broad range of technologies from lab to world scale applications. In 2009, Kurt joined Roche Diagnostics broadening his area of IP practice to consumer medical technology and devices in the area of Diabetes Care as a Senior Counsel and ultimately as Head of Patents Diabetes Care.
As Karsten, Kurt brings in relevant hands-on experience in the management of the multiple interfaces between internal and external R&D units, IP departments as well as other relevant stakeholders in the pharmaceutical industry as well as related technical areas.


Industry 1.490,00 €
Authorities/University 745,00 €
Students/full time 178,00 €
Alle Preise zzgl. VAT(19.00% MwSt.)



Tel.: +49 6131 97690
Fax: +49 6131 976969